Munder Capital Management’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q3
$3.97M Buy
288,800
+269,955
+1,433% +$3.71M 0.03% 324
2014
Q2
$290K Sell
18,845
-330
-2% -$5.08K ﹤0.01% 544
2014
Q1
$327K Sell
19,175
-825
-4% -$14.1K ﹤0.01% 545
2013
Q4
$259K Buy
+20,000
New +$259K ﹤0.01% 548